Gower sign positive muscle weakness in a patient with short stature and hypophosphatemia

Authors

  • Omyma Sabir Gaffar Ibn Auf Children Teaching Hospital, Khartoum. Sudan
  • Abdelaziz Elamin Gaffar Ibn Auf Children Teaching Hospital, Khartoum. Sudan.
  • Mohamed Elabyad Gaffar Ibn Auf Children Teaching Hospital, Khartoum. Sudan

DOI:

https://doi.org/10.52981/sjms.v5i2.1254

Abstract

A 17-year-old Sudanese patient presented with short stature, generalized body aches, and proximal
muscle weakness. He was seen by two orthopedic surgeons and an adult neurologist and
misdiagnosed as having benign bone cysts, osteomalacia and Duchenne muscular dystrophy. In
fact, he was suffering from severe hypophosphatemia, which manifest by unusual presentation. The
diagnostic pitfalls are explained and the importance of urinalysis and measurement of bone minerals
are emphasized.

References

1. Gattineni J, Baum M. Regulation of phosphatetransport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism. Pediatr Nephrol 2009; 133: 876-881.
2. Bastepe M, Jappner H. Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocrinol Metab Disord 2008; 9(2): 171-180.
3. Shaikh A, Berndt T, Kumar R. Regulation of phosphate homeostasis by the phosphatonins and other novel mediators. Pediatr Nephrol 2008; 23(8): 1203- 1210.
4. Skowroa R, Jawiak E, Lorenc RS. Metabolic bone disease in children: etiology and treatment options. Treat Endocrinol 2006; 5(5): 297-318.
5. Ward LM. Renal phosphate--wasting disorders in childhood. Pediatr Endocrinol Rev 2005; 2 (Suppl 3): 342-350.
6. Vaisbich MH, Koch VH. Hypophosphatemic rickets: results of a long-term follow-up. Pediatr Nephrol 2006; 21(2): 230-234.
7. Laroche M, Boyer JF. Phosphate diabetes, tubular phosphate reabsorption and phosphatonins. Joint Bone Spine 2005; 72(5): 376-381.
8. Cho HY, Lee BH, Kang JH, et al. A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res. 2005; 58(2): 329-333.
9. Gribaa M, Younes M, Bouyacoub Y, et al. An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab 2009; 78: 644-649.
10. Sochett E, Doria AS, Henriques F, et al. Growth and metabolic control during puberty in girls with Xlinked hypophosphataemic rickets. Horm Res 2004; 61(5): 252-256.
11. Esterberg J, Kassim RA, Redmon J et al. Hip pain in a case of hypophosphatemic osteomalacia. Am J Orthop 2003; 32(9): 455-458.
12. Wornell P, Crocker J, Wade A et al. An Acadian variant of Fanconi syndrome. Pediatr Nephrol 2007; 22(10): 1711-1715.
13. Nesterova G, Gahl W. Nephropathic cystinosis: late complications of a multisystem disease. Pediatr Nephrol 2008; 23(6): 863-878.
14. Servais A, Moriniare V, Granfeld JP, et al. Lateonset nephropathic cystinosis: clinical presentation, outcome, and genotyping. Clin J Am Soc Nephrol 2008; 3(1): 27-35.
15. Santer R, Steinmann B, Schaub J. Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport. Curr Mol Med 2002; 2(2): 213-227.
16. Bayrakci US, Baskin E, Ozcay F et al. Renal Fanconi syndrome and myopathy after liver transplantation: drug-related mitochondrial cytopathy? Pediatr Transplant 2008; 12(1): 109-112.
17. Au KM, Lau SC, Mak YF, et al. Mitochondrial DNA deletion in a girl with Fanconi's syndrome. Pediatr Nephrol 2007; 22(1): 136-140.
18. Cobeaas CJ, Rahman RC. A 3-year-old child withproteinuria and nephrocalcinosis. Suspicion of Dent disease. Pediatr Nephrol 2004; 19(11): 1300-1302.
19. Cheong HI, Lee JW, Zheng SH, et al. Phenotype and genotype of Dent's disease in three Korean boys. Pediatr Nephrol 2005; 20(4): 455-459.
20. Hsu SY, Tsai IJ, Tsau YK. Comparison of growth in primary Fanconi syndrome and proximal renal tubular acidosis. Pediatr Nephrol 2005; 20(4): 460-464.
21. Bagga A, Bajpai A, Menon S. Sporadic primary renal tubular disorders. Indian J Pediatr 2005; 72(9): 771-716.
22. Taylor HC, Elbadawy EH. Renal tubular acidosis type 2 with Fanconi's syndrome, osteomalacia, osteoporosis, and secondary hyperaldosteronism in an adult consequent to vitamin D and calcium deficiency: effect of vitamin D and calcium citrate therapy. Endocr Pract 2006; 12(5): 559-567.
23. Watanabe T, Yoshikawa H, Yamazaki S et al. Secondary renal Fanconi syndrome caused by valproate therapy. Pediatr Nephrol 2005; 20(6): 814- 817.
24. Watanabe T, Nakayasu K, Nagayama Y.Autoimmune hemolytic anemia and renal Fanconi syndrome caused by valproate therapy. Eur J Pediatr 2005; 164(3): 186-187.
25. Yoshikawa H, Watanabe T, Abe T. Fanconi syndrome caused by sodium valproate: report of three severely disabled children. Eur J Paediatr Neurol 2002; 6(3): 165-167.
26. Knorr M, Schaper J, Harjes M et al. Fanconi syndrome caused by antiepileptic therapy with valproic Acid. Epilepsia 2004; 45(7): 868-871.
27. Church DN, Hassan AB, Harper SJ et al. Osteomalacia as a late metabolic complication of Ifosfamide chemotherapy in young adults: illustrative cases and review of the literature. Sarcoma 2007; 27: 91586.
28. Skinner R. Chronic ifosfamide nephrotoxicity in children. Med Pediatr Oncol 2003; 41(3): 190-197.
29. Nissenkorn A, Korman SH, Vardi O, et al. Fanconi syndrome following ingestion of Chinese herbalmedicine in a Belgian lady of Moroccan origin. J Nephrol 2001; 16(9): 642-644.
30. Hong YT, Fu LS, Chung LH et al. Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs. Pediatr Nephrol 2006; 21(4): 577-579.

Downloads

Published

2021-08-22

Issue

Section

Original Articles